Table 1.
Demographic features and laboratory results for patients with hepatic phase and biliary phase fascioliasis
| Variables | Hepatic phase (mean ± SD) | Biliary phase (mean ± SD) |
| Age (yr) | 40 (19-79)1 | 41 (29-49)1 |
| Gender (M/F) | (5/17) | (1/7) |
| Hb (g/dL) | 12.5 ± 1.4 | 12.7 ± 1.57 |
| WBC (n/mm3) | 11862 ± 2829 | 8765 ± 1307 |
| Eosinophil (% of total WBC count) | 34.2 ± 16.2 | 14 ± 13.5 |
| Plt (n/mm3) | 290 ± 62 | 273 ± 70 |
| ESR (mm/h) | 48 ± 26 | 17 ± 12 |
| ALT (U/dL) | 44 ± 49 | 220 ± 217 |
| AST (U/dL) | 26 ± 9 | 260 ± 357 |
| ALP (U/dL) | 157 ± 65 | 166 ± 85 |
| GGT (U/dL) | 64 ± 40 | 226 ± 128 |
| Total bilirubin (U/dL) | 0.57 ± 0.32 | 1.65 ± 2.02 |
1
Age is represented using the median and range. Hb: Hemoglobin; WBC: White blood cell; Plt: Platelet; ESR: Erythrocyte sedimentation rate; ALT: Alanine aminotransferase (range, 10-40 U/L); AST: Aspartate aminotransferase (range, 10-35 U/L); GGT: γ glutamyl transferase (range, 9-64 U/L); ALP: Alkaline phosphatase (range, 40-150 U/L); Total bilirubin: range, 0.2-1.2 mg/dL; M: Male; F: Female.